CC[C@H]1[C@H](O)N2[C@H]3C[C@@H]1[C@@H]1[C@@H]2C[C@@]2(c4ccccc4N(C)[C@H]32)[C@H]1O
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?